Molecular Biomarkers and Translational Genomics Lab

Circulating Tumour DNA as a liquid biopsy for melanoma I Dr Stephen Wong

Circulating tumour DNA can be harnessed as a minimally-invasive biomarker to guide treatment decisions in melanoma patients.
Liquid biopsy to understand blood cancer evolution

Blood is the key: Minimally-invasive genomic testing to monitor pre-cancerous and cancerous blood conditions.